Detalhe da pesquisa
1.
Patient-reported symptom monitoring and adherence to therapy in patients with newly diagnosed chronic myeloid leukemia.
Cancer
; 130(2): 287-299, 2024 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37801052
2.
Incidence of blast phase in myelofibrosis patients according to anemia severity at ruxolitinib start and during therapy.
Cancer
; 130(8): 1270-1280, 2024 Apr 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-38153814
3.
Prediction of severe infections in chronic lymphocytic leukemia: a simple risk score to stratify patients at diagnosis.
Ann Hematol
; 103(5): 1655-1664, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38236391
4.
Long-term health-related quality of life and mental health in patients with immune thrombotic thrombocytopenic purpura.
Ann Hematol
; 2024 Apr 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-38671298
5.
The new Systematic Coronary Risk Evaluation (SCORE2 and SCORE2-OP) estimates the risk of arterial occlusive events in chronic myeloid leukemia patients treated with nilotinib or ponatinib.
Ann Hematol
; 103(2): 427-436, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-38012435
6.
Incidence of cancer and related deaths in hemoglobinopathies: A follow-up of 4631 patients between 1970 and 2021.
Cancer
; 129(1): 107-117, 2023 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36321594
7.
International validation of two EORTC questionnaires for assessment of health-related quality of life for patients with high-grade non-Hodgkin lymphoma (QLQ-NHL-HG29) and low-grade non-Hodgkin lymphoma (QLQ-NHL-LG20).
Cancer
; 129(17): 2727-2740, 2023 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37204189
8.
Ruxolitinib in cytopenic myelofibrosis: Response, toxicity, drug discontinuation, and outcome.
Cancer
; 129(11): 1704-1713, 2023 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36932983
9.
Real-world use of thrombopoietin receptor agonists in older patients with primary immune thrombocytopenia.
Blood
; 138(7): 571-583, 2021 08 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-33889952
10.
Renin-angiotensin inhibitors reduce thrombotic complications in Essential Thrombocythemia and Polycythemia Vera patients with arterial hypertension.
Ann Hematol
; 102(10): 2717-2723, 2023 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-37603060
11.
Risk of progression in chronic phase-chronic myeloid leukemia patients eligible for tyrosine kinase inhibitor discontinuation: Final analysis of the TFR-PRO study.
Am J Hematol
; 98(11): 1762-1771, 2023 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-37647134
12.
Understanding the User's Point of View: When the Doctor Gets Sick with Cancer and Seeks Help.
Clin Pract Epidemiol Ment Health
; 19: e17450179241325, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-38164454
13.
Peripheral blasts are associated with responses to ruxolitinib and outcomes in patients with chronic-phase myelofibrosis.
Cancer
; 128(13): 2449-2454, 2022 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35363892
14.
Deferasirox in the management of iron overload in patients with myelofibrosis treated with ruxolitinib: The multicentre retrospective RUX-IOL study.
Br J Haematol
; 197(2): 190-200, 2022 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-35137397
15.
International validation of the EORTC QLQ-CLL17 questionnaire for assessment of health-related quality of life for patients with chronic lymphocytic leukaemia.
Br J Haematol
; 197(4): 431-441, 2022 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35255152
16.
COVID-19 infection in chronic myeloid leukaemia after one year of the pandemic in Italy. A Campus CML report.
Br J Haematol
; 196(3): 559-565, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34636033
17.
Health-related quality of life profile of patients with immune thrombocytopenia in the real life is impaired by splenectomy.
Ann Hematol
; 101(4): 749-754, 2022 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-35098366
18.
Ruxolitinib rechallenge in resistant or intolerant patients with myelofibrosis: Frequency, therapeutic effects, and impact on outcome.
Cancer
; 127(15): 2657-2665, 2021 08 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33794557
19.
Second primary malignancy in myelofibrosis patients treated with ruxolitinib.
Br J Haematol
; 193(2): 356-368, 2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33222197
20.
Impact of comorbidities and body mass index on the outcome of polycythemia vera patients.
Hematol Oncol
; 39(3): 409-418, 2021 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-33590502